Bioxyne Limited (AU:BXN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioxyne Limited has issued 145 million new shares at $0.01 each, as part of a capital raise announced on April 18, 2024, complying fully with the relevant provisions of the Corporations Act. The company specializes in health and wellness products, including alternative therapeutics and investigational medicines, operating internationally with a significant presence in the UK, Europe, Japan, and Australia.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.